The CSIRO Innovation Fund

The CSIRO Innovation Fund invests in start-up and spin off companies, and SMEs engaged in the translation of research generated in the publicly funded research sector.

The CSIRO Innovation Fund invests in the development of early stage technology opportunities from the public research sector. This initiative is part of the Australian Government's National Innovation and Science Agenda .

Main Sequence Ventures is the manager of the CSIRO Innovation Fund 1, LP.

The CSIRO Innovation Fund is intended to help improve the translation of publicly funded research into commercial outcomes and stimulate innovation in Australia. This will help successful business to grow – boosting Australia's productivity and exports, and generating jobs through increased commercialisation of research outcomes, particularly in priority sectors of the Australian economy.

Commercialising early stage innovations

Working to get Australia's great science to market, improving our commercial outcomes and stimulating innovation in Australia.

Working with Main Sequence Ventures

The purpose of the Fund is to invest in start-up and spin off companies, and SMEs engaged in the translation of research generated in the publicly funded research sector.

The Fund will comprise a commitment of $70 million in government funding, $30 million revenue from CSIRO's WLAN programme and additional private sector investment, with a target total value of $200 million.

The Fund has a unique value proposition to investors and potential investment opportunities.

It is:

  • open to investment proposals from CSIRO, Australian universities, other Australian publicly funded research agencies, and their partners including SMEs
  • focused on proposals that bring forward the commercialisation of 'deep technology' across government-aligned national industry priorities as currently articulated through the Industry Growth Centres
  • investing for both commercial return and national benefit
  • focusing its investment toward companies establishing themselves and with most assets in Australia during their formative years.

Main Sequence Ventures

Main Sequence Ventures has been formed by CSIRO to manage the CSIRO Innovation Fund, and invests in early stage deep technology and science ventures with their origins in the Australian publicly-funded research sector. Main Sequence Ventures is custom designed for a new kind of founder in which science and technology run deep.

Please contact the Main Sequence Ventures team via the Main Sequence Ventures website .

Australia's innovation catalyst

The Fund, along with ON, Australia's national innovation accelerator , are key initiatives under CSIRO's Strategy 2020. These intensive, hands-on operations are focused on deal creation and lifting scientists' abilities in the fundamentals of customer first, product market fit and value creation by innovation.


The National Innovation and Science Agenda

NISA promotional banner
The National Innovation and Science Agenda


CSIRO Financial Services Pty Ltd trading as Main Sequence Ventures is managing the CSIRO Innovation Fund (CSIRO Innovation Fund 1, LP (ILP 170005) (the Fund)).

Information at this site is general information. CSIROFS holds an Australian financial services licence (AFS licence number 494111). By providing information on this website CSIROFS is not intending to, and is not, providing financial product advice. Nothing on this site is intended to provide, or imply, any recommendation or opinion about an investment in any financial product. CSIROFS recommends that prospective investors in financial products consider obtaining independent advice before making any financial decisions relating to any financial product.

Contact Main Sequence Ventures

Submit your enquiry via the online contact form.